10.1182/blood-2017-03-769620 - Outcomes in refractory diffuse large ...

This document has been corrected

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

10.1182/blood-2017-03-769620

Published Online: 2017-10-19

Journal: Blood•Publisher: American Society of Hematology

Authors: Annette Hay•Brian K. Link•Christian Gisselbrecht•Eric Van Den Neste•James R. Cerhan•Jason Westin•Jeff Wiezorek•John Kuruvilla•Lei Feng•Liting Zhu•Lynn Navale•Matthew J. Maurer•Michael Crump•Sami Boussetta•Sattva S. Neelapu•Umar Farooq•William Y. Go

This document has been corrected

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

10.1182/blood-2017-03-769620

Published Online: 2017-10-19

Journal: Blood

NOW

2018-02-01•Erratum

Crump M, Neelapu SS, Farooq U, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800-1808.

10.1182/blood-2017-11-817775

* information provided by CrossRef

2018-02-01•Erratum

10.1182/blood-2017-11-817775

* information provided by CrossRef

2017-10-19•Published

2018-02-01•Erratum

Crump M, Neelapu SS, Farooq U, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800-1808.

10.1182/blood-2017-11-817775

* information provided by CrossRef

This document has been corrected

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

10.1182/blood-2017-03-769620

Published Online: 2017-10-19

Journal: Blood•Publisher: American Society of Hematology